FDA Inspection
Rentschler Biopharma SERentschler Biopharma SE – FDA Inspection, Mar 7, 2023
Record Details
This FDA Inspection record concerns Rentschler Biopharma SE, with an inspection on March 7, 2023, issued by the Office of Inspections and Investigations.
- Company
- Rentschler Biopharma SE
- Inspection Date
- March 7, 2023
View Company Profile
ID · 300ac9e9-db9e-4c2e-a99e-94a03668b9ed
Inspection Facts
- Inspection number
- 1202157
- FDA center
- Human Drugs
Other FDA inspections of Rentschler Biopharma SE
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 5, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 9, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2018 | Not classified | Office of Inspections and Investigations | |
| May 23, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Rentschler Biopharma SE
- FDA Inspection 1246782 - 2023-05-05
- FDA Inspection 1160831 - 2021-02-26
- FDA Inspection 1102650 - 2019-08-09
- FDA Inspection 1046488 - 2018-03-08
- FDA Inspection 1022082 - 2017-05-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.